New York Personal Injury Attorney Blog
FDA Requires NAION Warning on All GLP-1 Drugs
|
On November 9, 2026, the U.S. Food and Drug Administration required the makers of every GLP-1 receptor agonist medication, including Ozempic, Wegovy, Mounjaro and Zepbound, to add information about a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) to the Warnings and Precautions section of their labeling. NAION is a rare eye condition…
Craig M. Silverman Discusses Ozempic and NAION on Fox Business’s The Evening Edit
|
Update: On November 9, 2026, the FDA required all GLP-1 medications to carry a warning about a potential increased risk of NAION. Read more. Sullivan Papain Firm Member Craig M. Silverman appeared on Fox Business Network’s The Evening Edit on November 6, 2026. He joined host Jason Chaffetz in studio to discuss the lawsuits…
Sullivan Papain Ranked Regional Tier 1 in 2027 Best Law Firms®
|
Sullivan Papain Block McManus Coffinas & Cannavo P.C. has been ranked Regional Tier 1 in five categories in the 2027 edition of Best Law Firms® by Best Lawyers. This is the third consecutive edition in which the firm has received all five rankings. 2027 Regional Tier 1 rankings Medical Malpractice Law – Plaintiffs: New York…
Sullivan Papain Attorneys Represent St. John’s Basketball Player Keyshawn Hall in NCAA Eligibility Dispute
|
October 15, 2026 Sullivan Papain attorneys Brian Shoot, TJ McManus, Glenn Nick, and Frank Floriani are representing St. John’s University basketball player Keyshawn Hall in an ongoing legal dispute with the National Collegiate Athletic Association (NCAA) over his eligibility to compete during the 2026–27 season. On October 13, 2026, the Honorable Supreme Court Justice Joseph…
Sullivan Papain Attorneys Recognized in the 2027 Edition of Best Lawyers® in America
|
Sullivan Papain Block McManus Coffinas & Cannavo P.C. is proud to announce that several of the firm’s attorneys have been selected for inclusion in the 2027 edition of The Best Lawyers in America® and Best Lawyers: Ones to Watch® in America. These prestigious recognitions reflect the firm’s commitment to advocating for plaintiffs in high-stakes personal…
